Alignment Healthcare Projects Strong 31% Membership Growth and Positive 2026 EBITDA Outlook
ALHC sits 84% above its 52-week low of $11.475.
Summary
Alignment Healthcare announced robust membership growth for 2026 and provided a positive outlook for its full-year 2026 adjusted EBITDA, while reaffirming its 2025 guidance.
Key Events · Earnings and Guidance · ALHC
-
Strong Membership Growth Reported
The company reported approximately 275,300 Health Plan Members as of January 1, 2026, representing 31% year-over-year growth.
-
Positive 2026 Membership Outlook
Alignment Healthcare expects 290,000 to 296,000 members by December 31, 2026, projecting 24% to 27% growth relative to year-end 2025 guidance.
-
2026 Adjusted EBITDA Expectation
The company anticipates its full-year 2026 adjusted EBITDA to be approximately $145 million, falling within its guidance range.
-
2025 Guidance Reaffirmed
Full-year 2025 guidance ranges for health plan membership, revenue, adjusted gross profit, and adjusted EBITDA were reaffirmed.
Analysis · ALHC · Finance
This 8-K filing provides key operational and financial updates ahead of investor meetings, signaling strong performance and future prospects. The projected 31% year-over-year membership growth as of January 1, 2026, and the forecast of 24% to 27% growth for year-end 2026 demonstrate significant expansion in the competitive Medicare Advantage market. Furthermore, the expectation that 2026 consensus adjusted EBITDA of approximately $145 million will be within the company's guidance range indicates confidence in future profitability. Reaffirming full-year 2025 guidance also provides stability and reduces uncertainty for investors. These updates are likely to reinforce investor confidence, especially as the company trades near its 52-week high.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALHC was trading at $21.10 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $11.48 to $21.65. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.